Actavia Life Sciences, Inc. (RASP)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
-0.0095 (-95.00%)
At close: Dec 26, 2025
Actavia Life Sciences Market Cap
Actavia Life Sciences has a market cap or net worth of $385.91 thousand as of April 29, 2026. Its market cap has decreased by -99.85% in one year.
Market Cap
385.91K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 14, 2016, Actavia Life Sciences's market cap has decreased from 71.15M to 385.91K, a decrease of -99.46%. That is a compound annual growth rate of -43.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 440.09K |
| THC Farmaceuticals | 326.37K |
| Sorrento Therapeutics | 489.34K |
| CNBX Pharmaceuticals | 490.31K |
| EV Biologics | 511.27K |
| Bio-Path Holdings | 515.69K |
| Regenerative Medical Technology Group | 525.56K |
| Eloxx Pharmaceuticals | 608.63K |